Nsaids + Risedronate Sodium Interaction
Moderateinteraction on record
Description
NSAID users developed upper gastrointestinal adverse reactions at 18% vs 13% in non-users taking Atelvia, suggesting increased GI risk with concurrent use.
Source: NLP:risedronate sodium